US Patent Issued to Astellas Pharma, National Cancer Center on May 20 for "Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibody" (Japanese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,951, issued on May 20, was assigned to Astellas Pharma Inc. (Tokyo) and National Cancer Center (Tokyo).

"Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibody" was invented by Yoshiyuki Tenda (Tokyo), Masatoshi Yuri (Tokyo), Daisuke Yamajuku (Tokyo), Takeshi Tsutsumi (Tokyo), Yuko Kusuzaki (Tokyo), Hiroki Sasaki (Chuo-ku, Japan), Fumiko Chiwaki (Chuo-ku, Japan) and Masayuki Komatsu (Chuo-ku, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An objective of the present invention is to provide an anti-TSPAN8/anti-CD3 bispecific antibody and an anti-TSPAN8 antibody usable in treatment or prevention in human. A human monoclonal antibody p...